[['name', 'investigation', 'route of administration', 'in - vitro / in - vivo', 'imaging / non - imaging'], ['i123 - iodide', 'thyroid uptake', 'oral or iv', 'in - vivo', 'non - imaging'], ['i123 - iodide', 'thyroid imaging thyroid metastases imaging', 'oral or iv', 'in - vivo', 'imaging'], ['i123 - o - iodohippurate', 'renal imaging', 'iv', 'in - vivo', 'imaging'], ['i123 - mibg (m - iodobenzylguanidine)', 'neuroectodermal tumour imaging', 'iv', 'in - vivo', 'imaging'], ['i123 - fp - cit', "spect imaging of parkinson 's disease", 'iv', 'in - vivo', 'imaging']]
the Route Of Administration for both I123 - O - Iodohippurate and I123 - Mibg (m - Iodobenzylguanidine) is Iv
the [ENT] for both [ENT] and [ENT] is [ENT]